Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

about

Pharmacogenomics and herb-drug interactions: merge of future and tradition The effect of grapefruit juice on drug disposition.Theranostics meets traditional Chinese medicine: rational prediction of drug-herb interactions.

P2860

Q27013047-36C9AD99-C817-4E8F-B614-C295532EA010 Q34764136-963FFD7E-7651-44BE-A4FC-815EFB107AB8 Q38068221-DAA607AC-3938-4534-9548-DFA193D3C579

P2860

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

Item

http://www.wikidata.org/entity/Q46968571

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@en

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@nl

type

Item

label

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@en

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@nl

prefLabel

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@en

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@nl

P1476

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

@en

P2093

Kagaya H

http://www.w3.org/2001/XMLSchema#string

Miura M

http://www.w3.org/2001/XMLSchema#string

Suzuki T

http://www.w3.org/2001/XMLSchema#string

Tada H

http://www.w3.org/2001/XMLSchema#string

Tateishi T

http://www.w3.org/2001/XMLSchema#string

Uno T

http://www.w3.org/2001/XMLSchema#string

Yasui-Furukori N

http://www.w3.org/2001/XMLSchema#string

P2860

Grapefruit juice-drug interactions

CYP3A gene expression in human gut epithelium

Active secretion and enterocytic drug metabolism barriers to drug absorption.

Drug interactions with grapefruit juice.

Enantioselective disposition of lansoprazole in relation to CYP2C19 genotypes in the presence of fluvoxamine.

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

Genetic polymorphism of CYP2C19 and lansoprazole pharmacokinetics in Japanese subjects.

Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes.

Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes.

Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction.

P304

95-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00498250500485065

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16507515

http://www.w3.org/2001/XMLSchema#string

P921

enantioselectivity

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

about

P2860

P2860

Intestinal CYP3A4 is not involved in the enantioselective disposition of lansoprazole.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921